Non-pharmaceutical Antioxidant Agents for Animal and Human Health
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 4015
Special Issue Editor
2. Department of Molecular Microbiology and Immunology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
Interests: in vitro models for disease; tissue repair/regeneration; osteoarthritis; nutraceuticals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Reactive oxygen species (ROS) are highly reactive molecules that play important roles in cellular functions in animals and humans. When present in excess, ROS are cytotoxic. Under normal physiologic conditions, the levels of these reactive molecules are regulated by the body’s antioxidant system. Oxidative stress results when the production of ROS exceeds the capacity of neutralizing antioxidants to detoxify excess ROS. Oxidative stress has been linked to a wide range of pathophysiological conditions, including inflammatory disorders, joint, cardiovascular, neurological diseases, metabolic disease such as diabetes mellitus, cancer, and aging. Some pharmacologic agents are reported to be efficacious in counteracting the adverse effects of oxidative stress. However, experimental and clinical studies have not provided consistent confirmatory evidence for the antioxidative stress efficacy of these drugs. Scientific interest has turned to non-pharmacologic agents as alternative therapies. This special issue focuses on plant-based agents as candidates to mitigate oxidative stress in aging and disease.
Dr. Carmelita Frondoza
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Reactive oxygen species
- Oxidative stress
- Plant-derived antioxidants
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
